Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

LCTX Lineage Cell Therapeutics Inc

0,8949

0,0331 (3,84%)

28 Sep 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
Von Aug 2024 bis Sep 2024

Click Here for more Lineage Cell Therapeutics Charts.

Lineage Cell Therapeutics (AMEX:LCTX)
Historical Stock Chart
Von Sep 2023 bis Sep 2024

Click Here for more Lineage Cell Therapeutics Charts.

News Lineage Cell Therapeutics Inc

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
Mittwoch 25 September 2024 (3 Tage vor) • Business Wire

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
Mittwoch 18 September 2024 (1 Woche vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 20 August 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 8 August 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 August 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 14 Juni 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 13 Juni 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 28 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 15 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Dienstag 14 Mai 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Lineage Cell Therapeutics Inc News-Artikel

NLBNPIT1WRE1 20351221 17...

Vontobel Financial Produ...

NLBNPIT1RYY5 20241220 20

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen